DR. DALLAS JOSEPH DE LA VARA MD
Prescription History 1235624321
Psychiatry & Neurology - Neurology in Orange, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DALLAS JOSEPH DE LA VARA MD, an active Neurology specialist practicing in Orange, CA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 69 documented patient claims. Among these therapy options, the most frequently utilized medication is Ubrelvy, which accounts for 22 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| UbrelvyUbrogepant | 22 | $1,545.07 | ≈ Typical |
About Ubrelvy: This medication is used to treat migraine. Show more ▾ Ubrogepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. This medication is not used to prevent future migraines or lessen how often you get migraines. A calcitonin gene-related peptide receptor antagonist (CGRP-RA), for the acute treatment of migraine. In 2024, this provider wrote 22 Medicare prescriptions for Ubrelvy, about 82% of the volume of the typical California prescriber of this medication (26.9). Medicare paid an average of $1,545.07 per fill, versus $1,155.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 18 | $3.83▼ below CA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 18 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical California prescriber of this medication (80.2). Medicare paid an average of $3.83 per fill, versus $15.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 20 30-Day Fills standardized to 30-day supplies 520 Days of Medication total across all patients in 2024 | |||
| Aimovig AutoinjectorErenumab-Aooe | 17 | $742.29▼ below CA avg | ▼ Less than typical |
About Aimovig Autoinjector: This medication is used to help prevent migraine. Show more ▾ This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks. Anti-human calcitonin gene-related peptide monoclonal antibody for the prevention of migraine headaches. In 2024, this provider wrote 17 Medicare prescriptions for Aimovig Autoinjector, about 63% of the volume of the typical California prescriber of this medication (26.8). Medicare paid an average of $742.29 per fill, versus $882.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 17 30-Day Fills standardized to 30-day supplies 494 Days of Medication total across all patients in 2024 | |||
| Sumatriptan Succinate | 12 | $11.76▼ below CA avg | ▼ Less than typical |
About Sumatriptan Succinate: Sumatriptan is used to treat migraines. Show more ▾ It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Sumatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Sumatriptan does not prevent future migraines or lessen how often you get migraine attacks. A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS. In 2024, this provider wrote 12 Medicare prescriptions for Sumatriptan Succinate, about half the volume of the typical California prescriber of this medication (23.8). Medicare paid an average of $11.76 per fill, versus $17.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12.5 30-Day Fills standardized to 30-day supplies 323 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. DALLAS JOSEPH DE LA VARA MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this Orange, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
